JASMINE MYERS: Open Payments
NPI 1447766019 · HUNTERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 11 payments from 9 companies in 2025. Trend: 2023 $235 · 2024 $0 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $73 |
| Actelion Pharmaceuticals US, Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| United Therapeutics Corporation | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: TRELEGY ELLIPTA, DUPIXENT, OPSYNVI, Tyvaso, FASENRA, REXULTI, Prolastin-C Liquid, Rybelsus.
Industry payments across NC — which companies pay providers there.
